India's Pharmaceutical Exports

Country Profile

Malta

Malta is a significant market for Indian pharmaceutical exports — $331M in FY 2025–26, with 5.1× growth over the past decade. Medicines accounts for 95% of shipments. The compound annual growth rate since FY2015 stands at 15.9%.

🇲🇹 $331M · 5.1× growth since FY2015 · 15.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$331M
Exports FY2025–26 DGCIS
5.1×
Growth FY2015→2026
15.9%
CAGR FY2015→2026
95%
Medicines Share
4
Product Categories Supplied
Malta is a significant market for Indian pharmaceutical exports — $331M in FY 2025–26, with 5.1× growth over the past decade. Medicines accounts for 95% of shipments. The compound annual growth rate since FY2015 stands at 15.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $315M (95.2%) Medicine Ingredients $15.8M (4.8%) Surgical & Hospital Supplies $48K (0.0%) Traditional & Herbal $16K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Malta in the RBI overseas direct investment dataset (2011–2026).